Literature DB >> 30676801

Conflict of Interest Provisions in State Laws Governing Medical and Adult Use Cannabis.

Candice M Bowling1, Stanton A Glantz1.   

Abstract

Although the acceleration of cannabis legalization in the United States has spurred innovations in public administration and policymaking, there have been news accounts of public employees engaged in cannabis licensure or enforcement that constitute conflicts of interest (COIs). After conducting 3 surveys in 50 states (including Washington, DC as a state), we found that COI provisions pertaining to cannabis-related public employment fell into 2 categories: subject matter general and cannabis specific. Only 20% (6/30) of the states that legalized medical cannabis had COI provisions in their medical cannabis codes, whereas the remaining 80% rely on subject matter general provisions relating to all areas of regulated subject matter, highlighting the need for thoughtful creation of COI rules in future policymaking. By contrast, 88% (7/8) of states that have legalized adult use cannabis put their COI provisions directly in their cannabis codes or regulations. Governments should enact cannabis-specific COI policies applicable to broadly defined categories of public employees that are responsive to the unique context of bringing cannabis from the black market into the regulated market.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30676801      PMCID: PMC6366528          DOI: 10.2105/AJPH.2018.304862

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  5 in total

1.  Migration: the trends converge.

Authors: 
Journal:  OECD Obs       Date:  1985-09

2.  Marijuana Initiatives Versus Legislation and Public Health.

Authors:  H Westley Clark
Journal:  Am J Public Health       Date:  2018-07       Impact factor: 9.308

3.  How four U.S. states are regulating recreational marijuana edibles.

Authors:  Camille Gourdet; Kristen C Giombi; Katherine Kosa; Jenny Wiley; Sheryl Cates
Journal:  Int J Drug Policy       Date:  2017-03-23

4.  Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017.

Authors:  Sarah B Klieger; Abraham Gutman; Leslie Allen; Rosalie Liccardo Pacula; Jennifer K Ibrahim; Scott Burris
Journal:  Addiction       Date:  2017-07-21       Impact factor: 6.526

5.  Marijuana Regulatory Frameworks in Four US States: An Analysis Against a Public Health Standard.

Authors:  Rachel A Barry; Stanton A Glantz
Journal:  Am J Public Health       Date:  2018-07       Impact factor: 9.308

  5 in total
  3 in total

1.  Public Health and Medicine's Need to Respond to Cannabis Commercialization in the United States: A Commentary.

Authors:  Candice M Bowling; Amy Y Hafez; Stanton A Glantz
Journal:  J Psychoactive Drugs       Date:  2020-05-19

2.  Population pharmacokinetic modeling of plasma Δ9-tetrahydrocannabinol and an active and inactive metabolite following controlled smoked cannabis administration.

Authors:  Cristina Sempio; Marilyn A Huestis; Susan K Mikulich-Gilbertson; Jost Klawitter; Uwe Christians; Thomas K Henthorn
Journal:  Br J Clin Pharmacol       Date:  2020-01-20       Impact factor: 4.335

3.  Civic Engagement in California Cannabis Policy Development.

Authors:  Candice Bowling; Stanton A Glantz
Journal:  J Psychoactive Drugs       Date:  2019-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.